Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety Article Proceedings Paper

publication date

  • March 1, 2009

webpage

keywords

  • desvenlafaxine succinate
  • hot flush
  • menopause
  • serotonin-norepinephrine reuptake inhibitor
  • vasomotor symptoms

volume

  • 200

issue

  • 3